ALKERMES, INC. for ALKERMES, INC.

Alcohol and Drug Abuse ALC

Advance the use and funding of FDA-approved medicines to treat addiction in criminal justice and public health settings; Expand funding and flexibility to address all substance use disorders;

Contacted: Justice, Dept of (DOJ); Substance Abuse & Mental Health Services Administration (SAMHSA); SENATE; Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES; Executive Office of the President (EOP); Veterans Affairs, Dept of (VA)

Medicare/Medicaid MMM

Patient access and maintain six protected classes for depressions and schizophrenia under Medicare Part D; Ensure patient access to behavioral health services and treatments through telehealth Inflation Reduction Act of 2022 implementation Medicaid Drug Rebate Program proposed rule Misclassification of Drugs, Program Administration and Program Integrity Updates Under the Medicaid Drug Rebate Program

Contacted: HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS); SENATE; Centers For Medicare and Medicaid Services (CMS)

Health Issues HCR

Awareness of the need for treatment system reform and access to all FDA-approved medications; Support patient-centered care and treatment that ensures comprehensive care and access to all FDA approved treatments; Awareness of outcomes data and the need for training on all medication assisted treatment; Ensure patient access to appropriate medications by limiting the unnecessary use of utilization management policies, including H.R. 2163/S. 464 the Safe Step Act Policies impacting pharmaceutical development, reimbursement, and patient access and cost Awareness of need for transparency and patient access within the 340B program H.R. 5894/S. 2624 - Labor, Health and Human Services, Education Appropriations, 2024 H.R. 5893/S. 2321 - Commerce, Justice, Science, and Related Agencies Appropriations, 2024 H.R. 4366/S. 2127 - Military Construction, Veterans Affairs, and Related Agencies Appropriations Bill, 2024 Support FDA health data privacy reforms

Contacted: Natl Institutes of Health (NIH); Substance Abuse & Mental Health Services Administration (SAMHSA); Office of Natl Drug Control Policy (NDCP); Health & Human Services, Dept of (HHS); SENATE; HOUSE OF REPRESENTATIVES; Executive Office of the President (EOP)

Bills named: S. 464 (118th), H.R. 2163 (118th), S. 2127 (118th), H.R. 5894 (118th), H.R. 4366 (118th), S. 2624 (118th), S. 2321 (118th), H.R. 5893 (118th)